Carregant...
P12. Long term treatment with erlotinib in advanced non-small cell lung cancer patients
BACKGROUND: Erlotinib is nowadays an established treatment for metastatic non-small cell lung cancer (NSCLC) patients with tumours harbouring epidermal growth factor receptor (EGFR) activating mutations. After a year of initial treatment most patients progress, but some very long responses have been...
Guardat en:
| Publicat a: | Transl Lung Cancer Res |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Pioneer Bioscience Publishing Company
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367785/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB024 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|